Notice of Change of Address on behalf of Aitken Klee LLP filed on 29-APR-2014

Acknowledgment of Receipt received from all parties, via facsimile, with respect to Doc. No. 126 placed on file on 07-APR-2014

Order dated 07-APR-2014 rendered by The Honourable Madam Justice McVeigh Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 107 Result: granted in part Filed on 07-APR-2014 copies sent to parties entered in J. & O. Book, volume 1225 page(s) 391 - 392 Interlocutory Decision

Covering letter from Respondent, Novopharm Limited, dated 28-MAR-2014 concerning Doc. No. 123 placed on file on 28-MAR-2014

Traduction certifiée conforme (texte français) des motifs de l'ordonnance et ordonnance rendus le 29-MAI-2008 par L'honorable Max M. Teitelbaum, juge suppléant déposée le 03-AVR-2014 en vertu de l'article 20 de la Loi sur les langues officielles Certificat de la traduction de l'ordonnance inscrit(e) dans le livre J. & O., volume 1225 page(s) 340 - 340 et placé au dossier.

Adjournment e-mail received on 04-APR-2014 from Jonathan Stainsby, on behalf of Applicants concerning Motion Doc. No. 107 currently scheduled to be heard at Special Sitting on 07-APR-2014 now withdrawn

Letter from Respondent, Teva Canada Limited, dated 03-APR-2014 in response to the Applicant's letter dated 01-APR-2014; received on 03-APR-2014

Letter from Applicant, Pfizer Canada Inc., dated 01-APR-2014 advising that Motion Doc. No. 116 is moot as the FCA rendered a decision on 28-MAR-2014 (A-292-09) and requesting that parties be able to submit responses for the Court's perusal prior to the hearing scheduled for 7-APR-2014; received on 01-APR-2014

Solicitor's certificate of service on behalf of Devin Doyle confirming service of Doc. No. 123 upon all parties by e-mail and courier on 28-MAR-2014 filed on 28-MAR-2014

Book of Authorities consisting of 1 volume(s) on behalf of Respondent, Novopharm Limited, received on 28-MAR-2014

Motion Record in response to Motion Doc. No. 116 containing the following original document(s): 121 122 Number of copies received: 3 on behalf of Respondent, Novopharm Limited, filed on 28-MAR-2014

Written Representations contained within a Motion Record on behalf of Respondent, Novopharm Limited, concerning Motion in writing Doc. No. 116 filed on 28-MAR-2014

Affidavit of Sean Jackson sworn on 26-MAR-2014 contained within a Motion Record on behalf of Respondent, Novopharm Limited, in opposition to Motion Doc. No. 116 with Exhibits "A"-"D" filed on 28-MAR-2014

Solicitor's certificate of service on behalf of W. Grant Worden confirming service of Doc 119 upon Novopharm Limited, Respondent by email and over-night courier on 18-MAR-2014 confirming service Doc 119 upon The Minister of Health, Respondent by email and same-day courier on 18-MAR-2014 filed on 18-MAR-2014

Motion Record containing the following original document(s): 116 117 118 Number of copies received: 3 on behalf of Applicant filed on 18-MAR-2014

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 116 filed on 18-MAR-2014

Affidavit of Diane Zimmerman sworn on 18-MAR-2014 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 116 with Exhibits A-R filed on 18-MAR-2014

Notice of Motion contained within a Motion Record on behalf of Applicant in writing to be placed before the Court in Ottawa for an Order adjourning Teva's motion sine die pending the determination of Teva's motion for directions as to costs in the Federal Court of Appeal filed on 18-MAR-2014

Acknowledgment of Receipt received from all parties with respect to Direction dated 6-MAR-2014 placed on file on 07-MAR-2014

Written directions received from the Court: Mireille Tabib, Prothonotary dated 06-MAR-2014 directing that "The adjournment will not be granted on the basis of Pfizer's informal request. Pfizer's concerns as to the interplay between this motion and a similar one pending before the Federal Court of Appeal has been known to it since well before the hearing was fixed. Written submissions should have been made at that time and could have informed the selection of a hearing date. Now that a hearing date has been set, Pfizer's request should have been brought by way of motion. The Court notes that Pfizer has indicated it would in any event raise its request for an adjournment as part of its responding record. The Judge assigned for the hearing of the motion may in his or her discretion deal with the request at or before the hearing." placed on file on 06-MAR-2014 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 04-MAR-2014 re: Request for adjournment sent to CMJ for consideration. (motion scheduled for 7-APR-2014)

Solicitor's certificate of service on behalf of Andrew M Shaughnessy confirming service of Doc 114 and a Book of Authority upon Respondent by email and courier on 03-MAR-2014 filed on 03-MAR-2014

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 03-MAR-2014

Motion Record in response to Motion Doc. No. 107 containing the following original document(s): 112 113 Number of copies received: 3 on behalf of Applicant filed on 03-MAR-2014

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 107 filed on 03-MAR-2014

Affidavit of Diane Zimmerman sworn on 03-MAR-2014 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 107 with Exhibits A-G filed on 03-MAR-2014

Letter from Applicant dated 28-FEB-2014 in reply to the letter dated February 28,2014 from counsel to the Respondent Teva...(scanned to Court for consideration with previous memo) received on 28-FEB-2014

Communication to the Court from the Registry dated 28-FEB-2014 re: Applicant's letter for adjournment of Teva's motion returnable 7-APR-2014 and positions of other parties sent to Court for consideration.

Letter from Respondent Novopharm (Teva) dated 28-FEB-2014 (email) in response to the letter of the Applicant dated February 13, 2014 requesting that the Court adjourn Teva's motion for directions as to costs sine die...(attached:Notice to the Profession 8-MAY-2013; 2008 FC 743; 2006 FC 1218) received on 28-FEB-2014

Letter from (email) Respondent Minister dated 24-FEB-2014 advising that the Minister takes no position regarding Pfizer's request (to adjourn Teva's motion sine die; letter dated 13-FEB-2014) received on 24-FEB-2014

Memorandum to file from Danielle Parent - Ottawa dated 24-FEB-2014 email sent to parties, further to letter from Pfizer dated 13-FEB-2014, seeking positions of all parties in respect of request for adjournment of motion. placed on file.

Letter from Applicant Pfizer Canada Inc. dated 13-FEB-2014 requesting that Teva's motion returnable on 7-APR-2014 be adjourned sine die pending the disposition of Teva's motion in A-292-09. received on 20-FEB-2014

Covering letter from Teva Canada Ltd. dated 10-FEB-2014 concerning Doc. Nos. 110 111 placed on file on 10-FEB-2014

Solicitor's certificate of service on behalf of Devin Doyle confirming service of doc. 110 and authorities upon all parties by courier on 10-FEB-2014 filed on 10-FEB-2014

Book of Authorities consisting of 1 volume(s) on behalf of Teva Canada Ltd. received on 10-FEB-2014

Motion Record containing the following original document(s): 107 108 109 Number of copies received: 3 on behalf of Teva Canada Ltd. filed on 10-FEB-2014

Written Representations contained within a Motion Record on behalf of Respondent concerning Motion Doc. No. 107 filed on 10-FEB-2014

Affidavit of Sean Jackson sworn on 09-FEB-2014 contained within a Motion Record on behalf of Respondent in support of Motion Doc. No. 107 with Exhibits A to S filed on 10-FEB-2014

Notice of Motion contained within a Motion Record on behalf of Teva Canada Ltd. returnable at Special Sitting in Ottawa on 07-APR-2014 to begin at 09:30 for an order issuing directions to the assessment officer filed on 10-FEB-2014

Transmittal report received from facsimile with respect to the Direction of the Chief Justice issued on December 2, 2013. placed on file on 02-DEC-2013

Written directions received from the Court: Chief Justice Crampton dated 02-DEC-2013 directing that "The Respondent Teva's motion for an order issuing directions to the assessment officer (document #105), may be made returnable before this Court at the Thomas D'Arcy McGee Building, 90 Sparks Street, in the City of Ottawa, Ontario, on Monday, the 7th day of April, 2014 at 9:30 in the forenoon for a duration of three (3) hours. The Respondent Teva's Motion record will be served and filed no later than February 10, 2014. The Applicant's responding motion record will be served and filed no later than March 3, 2014. placed on file on 02-DEC-2013 Confirmed in writing to the party(ies)

Memorandum to file from Danielle Parent - Ottawa dated 01-NOV-2013 letter ID:215 with Pfizer's availabilities was scanned to TrialJA for consideration. placed on file.

Letter from Applicant dated 30-OCT-2013 available dates for Teva's motion for directions as to costs... received on 30-OCT-2013

Letter from Respondent Novopharm dated 16-OCT-2013 providing dates of availability for the hearing of the motion for directions as to costs (scanned to JA's office) received on 18-OCT-2013

Communication to the Court from the Registry dated 04-JUL-2013 re: Motion document no. 105 and Rule 35 letter

Letter from Respondent, Novopharm Limited dated 03-JUL-2013 "(...) Teva is seeking pursuant to the attached Notice of Motion an Order seeking directions as to costs pursuant to Rule 403 (...)" received on 03-JUL-2013

Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of Notice of Motion of the Respondent, Novopharm Limited upon all parties by telecopier on 03-JUL-2013 filed on 03-JUL-2013

Notice of Motion on behalf of Respondent returnable (but no hearing date indicated at this time) for 1. An Order issuing directions to the assessment officer that Teva's costs be assessed on a solicitor and clients basis; 2. In the Alternative, an Order directing the Assessment Officer to tax Teva's costs at the high end of Column V of Tarriff B, and to include: (a) two counsel for appearance on motions; (b) counsel fee, for at least three counsel,for the preparation of affidavit evidence calculated at 10 units per counsel per affidavit; (c) two counsel for preparation and attendance at cross-examinations, where two counsel were present; (d) travel time and disbursements for two counsel attending cross- examinations; (e) travel costs and disbursements for preparation of expert reports; and (f) two counsel for the preparation of the Memorandum of Fact and Law and appearrance at the hearing of the Application. and other reliefs filed on 03-JUL-2013

Copy of JUDGEMENT and copy of REASONS FOR JUDGMENT in Appeal file dated 24-SEP-2010 rendered by Chief Justice Blais The Honourable Mr. Justice Nadon The Honourable Madam Justice Trudel placed on file. Original filed on Court File No. A-292-09

Certified French language Translation of Reasons for Order and Order rendered on 18-JUN-2009 by The Honourable Mr. Justice Kelen filed on 06-APR-2010 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Order entered in J. & O. Book, volume 1084 page(s) 345 - 345 and copy placed on file.

Order dated 11-SEP-2009 rendered by The Honourable Mr. Justice Kelen Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 91 Result: THIS COURT ORDERS THAT: 1. The assessment officer is directed as follows: a) the Applicants are entitled to their costs in the middle of Column IV; b) costs are permitted for first and second counsel for attendance at the hearing of the application, including costs for preparation and travel expenses; c) costs are permitted for first and second counsel (if present) at all cross-examinations by Pfizer and one counsel only in defending cross-examination by the respondnent Novopharm, including costs for preparation and travel expenses; and d) all applicable GST is permitted. 2. Costs of this motion shall be paid by the Respondent Novopharm Limited, to the Applicants in the fixed amount of $720. Filed on 11-SEP-2009 certified copies sent to parties entered in J. & O. Book, volume 1065 page(s) 50 - 51 Interlocutory Decision

Communication to the Court from the Registry dated 24-AUG-2009 re: Motion Doc. 91 (Directions to assessment officer)

Solicitor's certificate of service on behalf of VINCENT M. DE GRANDPRE confirming service of APPLICANTS' MOTION RECORD IN REPLY (DOC. 101) upon all parties by DOJ - SAME DAY COURIER, NOVOPHARM LTD. - EMAIL AND OVER-NIGHT COURIER on 06-AUG-2009 filed on 06-AUG-2009

Motion Record in response to Motion Doc. No. 91 containing the following original document(s): 100 Number of copies received: 3 on behalf of Applicant filed on 06-AUG-2009

Reply Representations contained within a Motion Record on behalf of Applicant in response to the opposing submissions doc. No. 98 to the Motion in writing Filed on 06-AUG-2009

Covering letter from the Respondent Novopharm dated 30-JUL-2009 concerning Responding Motion Record, Book of Authorities and Solicitor's Certificate of Service placed on file on 30-JUL-2009

Solicitor's certificate of service on behalf of David W. Aitken confirming service of Responding Motion Record doc # 98 & Book of Authorities upon the Applicants and the Respondent Minister of Health by e-mail and by courier on 30-JUL-2009 filed on 30-JUL-2009

Book of Authorities consisting of 1 volume(s) on behalf of the Respondent Novopharm (Motion for direction on Costs) received on 30-JUL-2009

Motion Record in response to Motion Doc. No. 91 containing the following original document(s): 97 Number of copies received: 3 on behalf of the Respondent Novopharm filed on 30-JUL-2009

Written Representations contained within a Motion Record on behalf of Respondent, Novopharm Limited concerning Motion Doc. No. 91 filed on 30-JUL-2009

Payment in the amount of $150.00 (ARV #1296) on behalf of applicants, Pfizer Canada Inc. received on 30-JUL-2009

Payment in the amount of $150.00 (ARV # 1297) on behalf of Respondent, Novopharm Limited received on 28-JUL-2009

****** CANCELLED ****** Letter from Respondent, Novopharm Limited dated 28-JUL-2009 Further to the Court's letter dated July 15, 2009, enclosing firm cheque in the amount of $150.00. ARV # 1297 received on 28-JUL-2009

Copy of Notice of Appeal (Appeal Court File No. A-292-09 ) appealing doc. no. 90 filed in the Court of Appeal on 20-JUL-2009 on behalf of Respondent placed on file on 22-JUL-2009

Solicitor's certificate of service on behalf of Vincent M. de Grandpré confirming service of Doc. 94 and the Applicant's Book of Authorities upon the Respondents by courier on 20-JUL-2009 filed on 20-JUL-2009

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 20-JUL-2009

Solicitor's Certificate of Vincent de Grandpré certify that the materials under seal in the Motion Record (Doc. 92) have been reviewed and no non- confidential informtion that is not otherwise available in a public version filed with the Court, or that cannot be reasonably segregated, has been sealed filed on 20-JUL-2009

Motion Record containing the following original document(s): 91 92 93 Number of copies received: 3 on behalf of Applicant filed on 20-JUL-2009

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion in writing Doc. No. 91 filed on 20-JUL-2009

Affidavit of Diane Zimmerman sworn on 17-JUL-2009 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 91 with Exhibits A-H filed on 20-JUL-2009

Notice of Motion contained within a Motion Record on behalf of Applicant in writing to be placed before the Court in Ottawa for an Order issuing directions to the assessment officer: (a) that the Court's order that the Applicants are entitled to their costs on the "mid scale of the tariff" be interpreted to mean the middle of the Column IV, as is now customary in proceedings under the Pateneted Medicines (Notice of Compliance Regulations; and other relief filed on 20-JUL-2009

Memorandum to file from Lise Lafrance dated 17-JUL-2009 Materials have been submitted in Court for the hearing and have been placed in annexes: T, U , V , YP, YQ, YR. placed on file.

Request to respondent for payment of Court fees for hearing over three days (ARV # 1297) placed on file on 15-JUL-2009

Request to Applicant for payment of Court fees for hearing over three days (ARV # 1296) placed on file on 15-JUL-2009

Reasons for Order and Order dated 18-JUN-2009 rendered by The Honourable Mr. Justice Kelen Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: granted THIS COURT ORDERS that: 1. This application is allowed and the Minister of Health is prohibited from issuing a Notice of Compliance to Novopharm for a generic version of Viagra until Pfizer's Patent .446 expires in 2014; and 2. the applicants are entitled to their costs on the mid scale of the tariff. Filed on 18-JUN-2009 certified copies sent to parties Final Decision Certificate of Order entered in J. & O. Book, volume 1057 page(s) 221 - 221

CONFIDENTIAL: Pfizer's Reply Compendium received at hearing on 08-MAY-2009

Pfizer's Reply Outline received at hearing on 08-MAY-2009

Supplementary Book of Authorities consisting of 1 volume(s) on behalf of Respondent Novopharm Limited received on 05-MAY-2009

CONFIDENTIAL: Novopharm's Compendium re: Sufficiency received at hearing on 05-MAY-2009

Novopharm's outline of oral argument re: Insufficiency received at hearing on 05-MAY-2009

Ottawa 05-MAY-2009 BEFORE The Honourable Mr. Justice Kelen Language: E Before the Court: Continuation of the Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Fredric Costin 05-MAY-2009 Jean Huneault 08-MAY-2009 Duration per day: 05-MAY-2009 from 09:30 to 16:10 Courtroom : Courtroom No. 1, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Marc Cossette 08-MAY-2009 from 09:30 to 14:55 Courtroom : Courtroom No. 1, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Marc Cossette Total Duration: 10.5h Appearances: Andrew Shaughnessy 416.865.8171 representing Applicant Andrew Bernstein 416.865.7678 representing Applicant Vincent de Grandpré 416.865.8139 representing Applicant Sandra Perri 416.865.8144 representing Applicant David Aitken 613.787.1077 representing Respondent Marcus Klee 613.235.2867 representing Respondent Comments: The following documents were submitted at the hearing: Novopharm's Outline of Oral Argument; Novopharm's Supplementary Book of Authorities; Novopharm's Compendium on Sufficiency; Pfizer's Reply Outline; Pfizer's Reply Compendium. Minutes of Hearing entered in Vol. 801 page(s) 432 - 449 Abstract of Hearing placed on file

'446 Patent on behalf of the Respondent - Novopharm Limited ***judge's copy with Kelen J. received at hearing on 30-APR-2009

CONFIDENTIAL Compendium (4 vols) on behalf of the Respondent - Novopharm Limited ***judge's copy with Kelen J. received at hearing on 30-APR-2009

"References to Sufficiency" on behalf of the Applicants ***judge's copy with Kelen J. received at hearing on 29-APR-2009

CONFIDENTIAL "Utility" Compendium on behalf of the Applicants received at hearing on 29-APR-2009

"Outline on Utility" on behalf of the Applicants ***judge's copy with Kelen J. received at hearing on 29-APR-2009

CONFIDENTIAL "Obviousness" Compendium (2 vols.) ***judge's copy with Kelen J. received at hearing on 28-APR-2009

"Outline - Obviousness" on behalf of the Applicants ***judge's copy with Kelen J. received at hearing on 28-APR-2009

CONFIDENTIAL "Sufficiency" Compendium on behalf of the Applicants ***judge's copy with Kelen J. received at hearing on 28-APR-2009

"Outline - Sufficiency" on behalf of the Applicants ***judge's copy with Kelen J. received at hearing on 28-APR-2009

CONFIDENTIAL "Opening" Compendium on behalf of the Applicants ***Judge's copy with Kelen J. received at hearing on 28-APR-2009

Toronto 28-APR-2009 BEFORE The Honourable Mr. Justice Kelen Language: E Before the Court: Judicial Review Result of Hearing: Matter adjourned to Special Sitting in Ottawa on 05-MAY-2009 to begin at 09:30 **Toronto portion of JR sitting has concluded and will resume in Ottawa held in Court Senior Usher: Ron Bradley Duration per day: 28-APR-2009 from 09:30 to 17:00 Courtroom : Courtroom No. 5-C - Toronto Court Registrar: Todd Desanti 29-APR-2009 from 09:32 to 16:53 Courtroom : Courtroom No. 5-C - Toronto Court Registrar: Todd Desanti 30-APR-2009 from 09:35 to 16:35 Courtroom : Courtroom No. 5-C - Toronto Court Registrar: Todd Desanti Total Duration: 3d Appearances: Andrew Shaughnessy (416) 865-8171 representing Applicants Andrew Bernstein (416) 865-7678 representing Applicants Vincent de Grandpre (416) 865-8139 representing Applicants Sandra Perri (416) 865-8144 representing Applicants David W. Aitken (613) 787-1077 representing Respondent - Novopharm Limited Marcus Klee (613) 787-1049 representing Respondent - Novopharm Limited Comments: Applicants submitted at hearing the following documents: CONFIDENTIAL "Opening" Compendium; "Outline on Utility" and CONFIDENTIAL "Utility" Compendium; "Outline - Sufficiency" and CONFIDENTIAL "Sufficiency" Compendium; "Outline - Obviousness" and CONFIDENTIAL "Obviousness" Compendium (2 vols.); "References to Sufficiency" Outline. Novopharm Limited submitted at hearing the following documents: CONFIDENTIAL Compendium (4 vols.) and a copy of the '446 patent. Minutes of Hearing entered in Vol. 800 page(s) 416 - 431 Abstract of Hearing placed on file

Supplementary Book of Authorities consisting of 1 volume(s) on behalf of Applicants received on 28-APR-2009

Letter from TORYS LLP (COUNSEL FOR APPLICANT) dated 09-APR-2009 RE: REQUEST FOR BREAKOUT ROOM FOR HEARING ON 28-APR-2009 TO 30-APR-2009 received on 09-APR-2009

Order dated 07-APR-2009 rendered by The Honourable Mr. Justice Kelen Matter considered with personal appearance The Court's decision is with regard to Meeting Result: THIS COURT ORDERS that: This hearing is hereby fixed for Tuesday, April 28th, Wednesday, April 29th, and Thursday, April 30th, 2009 to commence at 9:30 in the morning at the Federal Court, at the City of Toronto, Province of Ontario and on Tuesday, May 5th and Friday, May 8th, 2009 to commence at 9:30 in the morning at the Federal Court, at the City of Ottawa, Province of Ontario. Filed on 07-APR-2009 certified copies sent to parties and to the Toronto Local Office of this Court. Transmittal Letters placed on file. entered in J. & O. Book, volume 1051 page(s) 200 - 201 Interlocutory Decision

Ottawa 06-APR-2009 BEFORE The Honourable Mr. Justice Kelen Language: E Before the Court: Meeting to schedule the hearing of the application and its venue. Result of Hearing: Order to issue. held by way of Conference Call in chambers Duration per day: 06-APR-2009 from 11:00 to 11:17 Courtroom : Judge's Chambers - Ottawa Court Registrar: Marc Cossette Total Duration: 17m Appearances: Andrew Shaughnessy 416.865.8171 representing Applicant Andrew Bernstein 416.865.7678 representing Applicant David Aitken 613.787.1077 representing Respondent Marcus Klee 613.787.1049 representing Respondent Minutes of Hearing entered in Vol. 799 page(s) 136 - 137 Abstract of Hearing placed on file

Covering letter from Respondent dated 30-MAR-2009 concerning Book of Authorities and Doc 88 placed on file on 30-MAR-2009

Solicitor's certificate of service on behalf of David W. Aitken confirming service of Book of Authorities upon Applicants by courier on 30-MAR-2009 filed on 30-MAR-2009

Book of Authorities in YL, YM, YN & YO consisting of 4 volume(s) on behalf of Respondent received on 30-MAR-2009

Original Document (Doc. 70 filed 17-FEB-2009) returned to the Respondent Novopharm Limited, pursuant to Amended Order Doc. 85, on 27-MAR-2009 Remittal Advice placed on file on 27-MAR-2009

Covering letter from applicants dated 27-MAR-2009 concerning Doc. Nos. 86 87 placed on file on 27-MAR-2009

Solicitor's certificate of service on behalf of Marcus Klee confirming service of Doc#86 upon applicants by courier on 27-MAR-2009 filed on 27-MAR-2009

Sealed envelope pursuant to The order of Madam Tabib dated March 25, 2009 on behalf of Respondent(Novopharm Limited) purporting to contain Application Record of Novopharm Limited Filed on 27-MAR-2009

Amended Order rendered on 26-MAR-2009 by Mireille Tabib, Prothonotary filed on 26-MAR-2009 Matter considered without personal appearance amending Order Doc. 84: Novopharm shall withdraw the Memorandum filed 17-FEB-2009... entered in J. & O. Book, volume 1050 page(s) 138 - 145 Interlocutory Decision certified copies sent to parties Transmittal letters placed on file.

Letter from Applicant dated 26-MAR-2009 advising of a typographical error in the Order dated 25-MAR-2009 (at para. 1 the date Novopharm's Memorandum of Fact and Law was filed) and to inquire whether the Court may have inadvertently omitted the requirement of service of the replacement Memorandum. received on 26-MAR-2009

Order dated 25-MAR-2009 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 72 Result: granted in part "1. Novopharm shall withdraw from the Court record the memorandum of fact and law filed 15-DEC-2008, and replace it with a new memorandum of fact and law, as proposed in its motion record. 2. Costs of this motion shall be paid by the Respondent to the Applicant." Filed on 25-MAR-2009 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1050 page(s) 55 - 62 Interlocutory Decision

Toronto 11-MAR-2009 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 72 on behalf of Plaintiff Result of Hearing: Matter partially granted Novopharm to replace it's memorandum, costs will be referred to the hearings Judge. Breif endorsement to follow. held in Court Senior Usher: J. Jasenec Duration per day: 11-MAR-2009 from 01:30 to 04:30 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Michael Pace Total Duration: 3h Appearances: Andrew Bernstein 416-865-7678 representing Applicant Sandra Perri 416-865-8144 representing Applicant Marcus Klee 416-235-7234 representing Respondent Minutes of Hearing entered in Vol. 797 page(s) 352 - 354 Abstract of Hearing placed on file

Covering letter from Respondent dated 05-MAR-2009 concerning Doc. Nos. 80 81 82 placed on file on 05-MAR-2009

Solicitor's certificate of service on behalf of David W. Aitken confirming service of Responding Motion Record (Docs 80-82) upon Applicant by courier on 05-MAR-2009 filed on 05-MAR-2009

Sealed envelope purporting to contain: Confidential Schedule A to the Responding Motion Record (Doc 81) of the Respondents, further to Protective Order of Prothonotary Tabib, 31-OCT-2007. filed on 05-MAR-2009

Motion Record in response to Motion Doc. No. 72 containing the following original document(s): 80 Number of copies received: 3 on behalf of Respondent filed on 05-MAR-2009

Written Representations contained within a Motion Record on behalf of Respondent concerning Motion Doc. No. 72 filed on 05-MAR-2009

Solicitor's certificate of service on behalf of VINCENT M. DE GRANDPRE confirming service of REQUISITION FOR HEARING (DOC. 78) upon all parties by telecopier on 02-MAR-2009 filed on 02-MAR-2009

Requisition for hearing - Application from Applicant filed on 02-MAR-2009 Tariff Application or appeal - $50.00

Letter from Applicant dated 02-MAR-2009 RE: APPLICANTS' MOTION RECORD (DOC. 76) received on 02-MAR-2009

Solicitor's certificate of service on behalf of ANDREW BERNSTEIN confirming service of APPLICANTS' MOTION RECORD (DOC. 76) upon RESPONDENT - NOVOPHARM INC. by COURIER on 27-FEB-2009 confirming service APPLICANTS' MOTION RECORD (DOC. 76) upon RESPONDENT - MOH by COURIER on 02-MAR-2009 filed on 02-MAR-2009

Motion Record containing the following original document(s): 72 74 75 Number of copies received: 3 on behalf of APPLICANTS (PARTIALLY SEALED)_ filed on 02-MAR-2009

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 72 filed on 02-MAR-2009

Affidavit of CHRISTINE INGHAM (PARTIALLY SEALED) sworn on 27-FEB-2009 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 72 with Exhibits A-G filed on 02-MAR-2009

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 27-FEB-2009 directing that the hearing of Pfizer's ,motion will take place beginning at 1:30 p.m., on March 11, 2009, in Toronto, for a duration not exceeding 2 hours. The Applicant's motion record shall be served and filed no later than March 2, 2009, and the Respondent's responding record shall be served and filed no later than March 6, 2009 placed on file on 27-FEB-2009 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 24-FEB-2009 re: scheduling of the applicant's motion doc 72

Covering letter from Applicant dated 20-FEB-2009 concerning Doc. No. 72 placed on file on 20-FEB-2009

Solicitor's certificate of service on behalf of A. Bernstein confirming service of Notice of motion dated 20-Feb-2009 upon all parties by telecopier on 20-FEB-2009 filed on 20-FEB-2009

Notice of Motion on behalf of Applicant returnable (but no hearing date indicated at this time) for an Order striking part of the respondent's memo of fact and law and allowing them to file a revised memo of fact and law filed on 20-FEB-2009

Covering letter from Respondent, Novopharm Limited dated 17-FEB-2009 concerning Doc. Nos. 70 71 placed on file on 17-FEB-2009

Solicitor's certificate of service on behalf of Marcus Klee confirming service of doc. no. 70 upon Applicant by email and courier on 17-FEB-2009 confirming service doc. no. 70 upon the Respondent, the Minister of Health by email and courier on 17-FEB-2009 filed on 17-FEB-2009

****** REMOVED ****** Sealed envelope pursuant to Protective Order (Tabib, P.) dated 31-OCT-2007 on behalf of Respondent, Novopharm Limited purporting to contain Application Record Filed on 17-FEB-2009

****** CANCELLED ****** Sealed envelope pursuant to Protective Order (Tabib, P.) dated 31-OCT-2007 on behalf of Respondent, Novopharm Limited purporting to contain Application Record Filed on 18-FEB-2009

Solicitor's certificate of service on behalf of Vincent de Grandpre confirming service of authorities upon Novopharm Inc. & Minister of Health by courier on 05-FEB-2009 filed on 05-FEB-2009

Book of Authorities consisting of 2 volume(s) on behalf of Applicant received on 05-FEB-2009

Memorandum to file from Toronto dated 18-DEC-2008 there are three copies of the Application Record two of which have confidential material and one excluding the confidential material made available to the public. placed on file.

Solicitor's certificate of service on behalf of Vincent de Grandpre confirming service of doc. 66 upon Respondent by courier on 17-DEC-2008 confirming service doc. 66 upon all parties by courier on 18-DEC-2008 filed on 18-DEC-2008

Application Record Number of copies received/prepared: 2 on behalf of Applicant with consent to extend the time for filing filed on 18-DEC-2008 Document placed in Annexes L M N O P Q VD VE VF VG VH VI VJ

Written directions received from the Court: Mireille Tabib, Prothonotary dated 16-DEC-2008 directing that subject to the conditions expressed in counsel's letter dated December 15, 2008 the applicant's request for extension of time is granted (until December 18th, 2008) placed on file on 16-DEC-2008 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 15-DEC-2008 re: applicant's letter dated 15-Dec-2008

Letter from Applicants(Pfizer) dated 15-DEC-2008 an extension of time (on consent) to serve and file their application record received on 15-DEC-2008

Order dated 19-NOV-2008 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: "1. The time within which the parties are to complete cross-examinations on affidavits is extended, nunc pro tunc, to 11-NOV-2008. 2. The Applicants' Record shall be served and filed no later than 15-DEC-2008. 3. The Respondents' Records shall be served and filed no later than 16-FEB-2009. 4. Both parties have leave to serve and file memoranda of fact and law exceeding 30 pages in length but not exceeding 45 pages in length. 5. The hearing of this Application shall take place in Toronto beginning at 9:30 a.m. on 27-APR-2009 for a duration of 5 days." Filed on 20-NOV-2008 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1039 page(s) 135 - 136 Interlocutory Decision

Ottawa 18-NOV-2008 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: An Order will issue fixing the Hearing of the Application to be held in Toronto beginning 27-APR-2009 for a duration of 5 days held in chambers by way of Conference Call Duration per day: 18-NOV-2008 from 10:00 to 10:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 15min Appearances: Andrew Bernstein and Vincent de Grandpré (416) 865-7678 representing Applicant Marcus Klee (613) 787-1049 representing Respondent Novopharm Limited * no one appearing * representing Respondent Minister of Health Comments: The schedule for remaining steps will be amended as follows: -Applicants' Record to be served and filed by 15-DEC-2008; Respondents' Records to be served and filed by 16-FEB-2009. The parties' joint request for leave to file Memoranda of Fact and Law up to 45 pages in length is granted. Minutes of Hearing entered in Vol. 788 page(s) 478 - 480 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 14-NOV-2008 directing that a case management telephone conference will take place at 10:00 a.m. on 18-NOV-2008. placed on file on 14-NOV-2008 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-NOV-2008 re: letter dated 12-NOV-2008

Letter from Respondent Novopharm Limited dated 12-NOV-2008 advising that cross-examinations could not be completed within the time set out in the Scheduling Order dated 31-OCT-2007; requesting a case management conference to amend the schedule for remaining steps in the Application and to secure the Court's assistance in setting a hearing date. received on 12-NOV-2008

Copy of Judgment, Reasons for Judgment dated 15-SEP-2008 rendered by The Honourable Madam Justice Desjardins The Honourable Mr. Justice Linden The Honourable Mr. Justice Evans placed on file. Original filed on Court File No. A-348-08

Solicitor's certificate of service on behalf of Marcus Klee confirming service of Sur-reply evidence of the respondent upon applicants by courier on 26-AUG-2008 filed on 04-SEP-2008

Solicitor's certificate of service on behalf of Andrew Bernstein confirming service of Reply Affidavits of Dr. Ellis sw. 14-AUG-2008, Dr. Brock sw. 28-JUL-2008 and Dr. Francis sw. 30-JUL-2008 (not filed - see Order dated 22-AUG-2008) upon Respondents by courier on 25-AUG-2008 filed on 25-AUG-2008

Order dated 22-AUG-2008 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 20-AUG-2008 re: Motion Doc. 59 Result: granted "1. Pfizer is granted leave to serve and file as part of its Application Record the reply evidence of Drs. Peter Ellis, Gerald Brock and Sharron Francis, in the form (whether sworn or unsworn) included in Pfizer's motion record. 2. Novopharm is granted leave to serve and file as part of its responding motion record the sur-reply evidence of Drs. Inigo Sanenz de Tejada, Jonathan Dordick and Donald Maurice in the form (whether sworn or unsworn) previously provided to Pfizer. 3. Within 10 days of this Order, Pfizer and Novopharm shall serve on all parties sworn copies of the affidavits referred to in paragraph 1 and 2 above. 4. The requirement of filing the affidavits referred to above is dispensed with, but the parties shall file proof of service within 10 days of serving their affidavits. 5. There are to be no costs of this motion." Filed on 22-AUG-2008 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1032 page(s) 157 - 158 Interlocutory Decision

Letter from Applicant dated 20-AUG-2008 advising that the parties have reached an agreement re: Motion Doc. 59; consent and draft order attached for the Court's consideration. received on 20-AUG-2008

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 05-AUG-2008 directing that 1. The respondent's affidavits shall be served by AUgust 12, 2008 2. Cross- examinations, if any, shall be completed by August 22, 2008. 3. The applicant's supplementary submissions arising out of the cross-examinations shall be served and filed by August 27, 2008. 4. The respondent's record shall be served and filed by August 29th, 2008 and 5. The hearing of the applicant's motion is scheduled on September 3, 2008 at 9:30 a.m., in Ottawa for half a day placed on file on 05-AUG-2008 Confirmed in writing to the party(ies)

Ottawa 05-AUG-2008 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to schedule the hearing of motion doc 59 Result of Hearing: 1. The respondent shall serve it's affidavits by 12-Aug-2008 2. Cross- examinations if any shall be completed by August 22, 2008 3.The applicant's supplementary submissions arising out of the cross-examinations shall be served and filed by 27-Aug-2008 4. Respondent's record shall shall be served and filed by 29-Aug-2008. 5. The hearing of the applicant's motion is scheduled on 3-Sep-2008, in Ottawa, starting at 9:30 a.m. for a duration of half a day. held in chambers by way of Conference Call Duration per day: 05-AUG-2008 from 02:20 to 02:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 15min Appearances: Andrew Shaughnessy 416-865-8171 representing Applicant David Aitken & Marcus Klee 613-787-1077 representing Respondent Novopharm no one appearing - representing Respondent Minister Minutes of Hearing entered in Vol. 781 page(s) 344 - 346 Abstract of Hearing placed on file

Public Version of the Applicant's Motion Record filed under seal on July 30, 2008 received on 01-AUG-2008

Solicitor's certificate of service on behalf of Vincent de Grandpré confirming service of doc 60 upon the Respondents by courier on 30-JUL-2008 filed on 30-JUL-2008

Book of Authorities consisting of 1 volume(s) on behalf of Applicants received on 30-JUL-2008

Sealed envelope pursuant to Protective Order dated 31-OCT-2007 on behalf of the Applicants purporting to contain Motion Record to strike/file evidence (2 volumes) Filed on 30-JUL-2008

Notice of Motion contained within a Motion Record on behalf of Applicants returnable (but no hearing date indicated at this time) for an Order striking out certain evidence filed by the Respondent and other relief. (Andrew Bernstein 416-865-7678/Vincent de Grandpré 416-865-8169/ Sandra Perri 416-865-8144) filed on 30-JUL-2008

Letter from the Applicants dated 30-JUL-2008 enclosing Motion Record to strike or file reply evidence, and Certificate of Service. The entire Motion Record is filed under seal pursuant to Protective Order dated 31-OCT-2007. The Applicants undertake to file a redacted, public version of the motion record no later than 1-AUG-2008, once Pfizer and the Respondent have reached an understanding as to which portions of the Record may be made available to the public. Respondent's counsel cc'd. received on 30-JUL-2008

Ottawa 18-JUL-2008 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: A further Case Management Conference will be held on 5-AUG-2008 at 2:00 p.m. held in chambers by way of Conference Call Duration per day: 18-JUL-2008 from 12:38 to 12:59 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 21 min Appearances: Andrew Bernstein and Vincent de Grandpré (416) 865-7678 representing Applicant David Aitken and Marcus Klee (613) 787-1077 representing Respondent Novopharm Ltd. * no one appearing * representing Respondent Minister of Health Comments: The Applicants are to serve and file a Motion Record to strike portions of Novopharm's evidence and for leave to file reply evidence as soon as possible, and in any event no later than 30-JUL-2008. A schedule for Novopharm's responding Motion Record and the hearing of the Motion is to be established during the case management teleconference on 5-AUG-2008. Mr. Bernstein requested the registrar note that Mr. Andrew Shaughnessy [(416) 865-8171] will participate on behalf of the Applicants on 5-AUG-2008. Minutes of Hearing entered in Vol. 779 page(s) 462 - 465 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 16-JUL-2008 directing that A case management telephone conference will be held on 18-JUL-2008 at 12:30 p.m. placed on file on 16-JUL-2008 Confirmed in writing to the party(ies)

Letter from Andrew Bernstein (counsel for the Applicant) dated 11-JUL-2008 requesting a case conference to discuss certain issues arising from the evidence. Dates of mutual availability provided. (cc.All Respondents) received on 11-JUL-2008

Letter from Applicant dated 11-JUL-2008 requesting a case management conference with Madam Prothonotary Tabib to discuss issues arising from the Respondents' evidence received on 11-JUL-2008

Copy of Notice of Appeal (Appeal Court File No. A-348-08 ) appealing the Decision of Teitelbaum, D.J. dated 29-MAY-2008 filed in the Court of Appeal on 27-JUN-2008 on behalf of Applicant placed on file on 07-JUL-2008

Solicitor's certificate of service on behalf of David W. Aitken confirming service of the evidence of the Respondent, Novopharm Limited upon Applicant by email and courier on 03-JUL-2008 filed on 04-JUL-2008

Invoice from Court Reporter received on 27-MAY-2008

Reasons for Order and Order dated 29-MAY-2008 rendered by The Honourable Max M. Teitelbaum, Deputy Judge Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 49 Result: This Court Orders that Pfizer's motion to set aside the Order of Prothonotary Tabib, dated April 18, 2008, is dismissed. Costs are awarded to the Respondents on a party to party basis. Filed on 29-MAY-2008 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1024 page(s) 172 - 172

Ottawa 22-MAY-2008 BEFORE The Honourable Max M. Teitelbaum, Deputy Judge Language: E Before the Court: Motion Doc. No. 49 on behalf of Applicants Result of Hearing: Matter reserved held in Court Senior Usher: S. Young Duration per day: 22-MAY-2008 from 09:30 to 12:45 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Jennifer Jones Total Duration: 3h15min Appearances: Vincent de Grandpré & Ms. Yael Bienenstock 416-865-8139 representing Applicants David Aitken & Geoffrey North 613-787-1077 representing Respondent Novopharm Ltd. Court Reporter: Noel C. Keeley, CSR 613-233-8601 22-MAY-2008 Transcript not requested Minutes of Hearing entered in Vol. 776 page(s) 205 - 212 Abstract of Hearing placed on file

Letter sent by Registry on 21-MAY-2008 to ASAP Reporting Services, Nathalie Fisher confirming the requirement for a Court Reporter for the motion being heard in Courtroom 1104, TDM Building, on Thursday, May 22, 2008 at 9:30 a.m Copy placed on file.

Oral directions received from the Court: The Honourable Max M. Teitelbaum, Deputy Judge dated 20-MAY-2008 directing that the Respondent, Novopharm, file their record in reply to the Applicants' Motion no later than 11:00 a.m. Wednesday, May 21, 2008. placed on file on 20-MAY-2008

Covering letter from Respondent dated 20-MAY-2008 concerning Doc. Nos. 54 55 placed on file on 20-MAY-2008

Solicitor's certificate of service on behalf of Geoffrey J. North confirming service of 54 55 upon Applicant by courier on 20-MAY-2008 filed on 20-MAY-2008

Motion Record in response to Motion Doc. No. 49 containing the following original document(s): 54 Number of copies received: 3 on behalf of Respondent filed on 20-MAY-2008

Written Representations contained within a Motion Record on behalf of Respondent concerning Motion Doc. No. 49 filed on 20-MAY-2008

Solicitor's certificate of service on behalf of Vincent de Grandpré confirming service of Doc 52 upon Respondents by courier on 13-MAY-2008 filed on 14-MAY-2008

Book of Authorities consisting of 1 volume(s) on behalf of Applicants received on 14-MAY-2008 Sent directly to Presiding Judge

Motion Record containing the following original document(s): 49 51 Number of copies received: 3 on behalf of Applicants filed on 14-MAY-2008

Written Representations contained within a Motion Record on behalf of Applicants concerning Motion Doc. No. 49 filed on 14-MAY-2008

Covering letter from Applicant dated 14-MAY-2008 concerning Applicants Motion Record placed on file on 14-MAY-2008

Correction to General Sitting concerning Motion Doc. No. 49 Hearing added to General Sitting at Ottawa on 22-MAY-2008 at 09:30 duration: 2h Language: E Reason for correction: Letter from Applicant dated 7-MAY-2008

Letter from Applicant dated 07-MAY-2008 after consultation with counsel for the Respondent Novopharm Ltd., requesting Motion Doc. 49 be made returnable at General Sittings in Ottawa on 22-MAY-2008. received on 07-MAY-2008

Solicitor's certificate of service on behalf of Yael Bienenstock confirming service of doc 49 upon Respondent by telecopier on 28-APR-2008 filed on 28-APR-2008

Notice of Motion on behalf of Applicant returnable (but no hearing date indicated at this time) for an appeal of the decision of Mireille Tabib, Prothonotary dated 18-APR-2008 filed on 28-APR-2008

Order dated 18-APR-2008 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion in writing Doc. No. 18 Result: granted "1. The within Application, as it relates to Canadian Patent No. 2,044,748 is dismissed. 2. Costs of this motion are awarded in favour of the Respondent Novopharm. 3. The parties are given leave, in any appeal of the present order, to rely on the motion record as constituted on the present motion." Filed on 18-APR-2008 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1019 page(s) 165 - 171 Interlocutory Decision

Toronto 01-APR-2008 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 18 on behalf of Respondent Novopharm Ltd. for an Order dismissing the Application Result of Hearing: Matter reserved held in Court Senior Usher: Bill Evans Duration per day: 01-APR-2008 from 09:30 to 12:00 Courtroom : Courtroom No. 6-A - Toronto Court Registrar: Stan Shepherd Total Duration: 2h 30min Appearances: Vincent de Grandpré & Yael Bienenstock 416-865-8139 representing Applicant David Aitken & Geoffrey North 613-787-1077 representing Respondent Minutes of Hearing entered in Vol. 771 page(s) 468 - 476 Abstract of Hearing placed on file

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 28-MAR-2008

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 18 filed on 28-MAR-2008

Solicitor's certificate of service on behalf of Vincent de Grandpré confirming service of doc.45 upon all parties by personal service on 28-MAR-2008 filed on 28-MAR-2008

Motion Record in response to Motion Doc. No. 18 containing the following original document(s): 42 43 44 47 Number of copies received: 3 on behalf of Applicant filed on 28-MAR-2008

Affidavit of Christine Ingham sworn on 03-MAR-2008 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 18 with Exhibits A-K filed on 28-MAR-2008

Affidavit of Christine Ingham sworn on 03-MAR-2008 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 18 with Exhibits 1-5 filed on 28-MAR-2008

Affidavit of Darren Noseworthy sworn on 03-MAR-2008 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 18 with Exhibits a filed on 28-MAR-2008

Solicitor's certificate of service on behalf of LEIGH A. WALTERS confirming service of MOTION RECORD (DOC. 40) upon all parties by personal service on 26-MAR-2008 filed on 26-MAR-2008

Covering letter from RESPONDENT (NOVOPHARM LIMITED) dated 26-MAR-2008 concerning Doc. No. 40 placed on file on 26-MAR-2008

BOOK OF AUTHORITIES (RE: MOTION DOC. 18) consisting of 1 volume(s) on behalf of RESPONDENT (NOVOPHARM LIMITED) received on 26-MAR-2008

Motion Record containing the following original document(s): 18 38 39 Number of copies received: 3 on behalf of RESPONDENT (NOVOPHARM LIMITED) filed on 26-MAR-2008

Written Representations contained within a Motion Record on behalf of RESPONDENT (NOVOPHARM LIMITED) concerning Motion Doc. No. 18 filed on 26-MAR-2008

Affidavit of BRYAN NORRIE sworn on 01-FEB-2008 contained within a Motion Record on behalf of RESPONDENT (NOVOPHARM LIMITED) in support of Motion Doc. No. 18 with Exhibits A-G filed on 26-MAR-2008

Solicitor's certificate of service on behalf of Vincent de Grandpré confirming service of Applicants evidence in opposition to Novopharms motion to dismiss. upon Respondent Novopharm by e-mail on 03-MAR-2008 filed on 06-MAR-2008

Solicitor's certificate of service on behalf of Vincent de Grandpré confirming service of Applicants evidence relating to the within Application upon Respondent Novopharm by e-mail on 03-MAR-2008 filed on 06-MAR-2008

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 04-MAR-2008 directing that "The hearing (of Motion Doc. 18) scheduled for 1-APR-2008 will take place in Toronto instead of Ottawa. The Court appreciates the Respondent's indulgence in accepting the change of venue." placed on file on 04-MAR-2008 Confirmed in writing to the party(ies)

Order dated 04-MAR-2008 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 17 Result: granted "1. This Application is dismissed in part, as it related to Patent No. 2,277,017, Patent No. 2,285,733, Patent No. 2,299,266 and Patent No. 2,324,324. 2. Costs of this Motion are awarded against the Applicants in favour of the Respondent Novopharm Limited as a contested Motion at the uppermost end of Column III of Tariff B." The Court's decision is with regard to Oral motion on behalf of the Applicants objecting to the filing of the Affidavit of Bryan Norrie sworn 18-JAN-2008 in support of Motion Doc. 17 Result: dismissed -the Norrie affidavit is accepted for filing and considered on this Motion Filed on 04-MAR-2008 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1015 page(s) 264 - 273 Interlocutory Decision

Ottawa 23-JAN-2008 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 17 on behalf of the Respondent Novopharm Limited Result of Hearing: Matter reserved held in chambers by way of Conference Call Duration per day: 23-JAN-2008 from 09:30 to 11:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 2h Appearances: Vincent de Grandpré and Jason Gilman (416) 814-3044 *for today only* representing Applicant David Aitken and Geoffrey North (613) 787-1077 representing Respondent Novopharm Ltd. Minutes of Hearing entered in Vol. 766 page(s) 429 - 435 Abstract of Hearing placed on file

Letter from Applicant dated 22-JAN-2008 outlining their position with respect to Novopharm's affidavit regarding costs submitted 18-JAN-2008 received on 22-JAN-2008

Covering letter from Respondent Novopharm Limited dated 18-JAN-2008 concerning Doc. No. 34 placed on file on 18-JAN-2008

Affidavit of Bryan Norrie sworn on 18-JAN-2008 on behalf of Respondent Novopharm Limited in support of submissions regarding costs in relation to Motion Doc. 17 with Exhibits A to C with proof of service upon all parties on 18-JAN-2008 filed on 18-JAN-2008

Letter from Applicant dated 18-JAN-2008 notifying of change of address of solicitor to: suite 1900,340 Albert Street Ottawa ON K1R 7Y6 tel:613-235--7234 / fax:613-235-2867 received on 18-JAN-2008

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 17-JAN-2008 directing that "Any outstanding issue on the motion scheduled to be heard on 23-JAN-2008, including costs, may be heard by telephone conference on that day." placed on file on 18-JAN-2008 Confirmed in writing to the party(ies)

Letter from Respondent Novopharm Limited dated 17-JAN-2008 in response to the Applicants' letter dated 16-JAN-2008 received on 17-JAN-2008

Letter from Applicant dated 16-JAN-2008 advising that Pfizer has received notice that the Minister has removed the '017, '733, '766 and '324 Patents from the Register; therefore Pfizer no longer has a basis to oppose Novopharm's Motion to dismiss the Application as it relates to these Patents. The Application will therefore continue only on the basis of the two Patents that are not the subject of Novopharm's Motion (scheduled to be heard 23-JAN-2008)... received on 16-JAN-2008

Order dated 08-JAN-2008 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 21 Result: granted *Protective Order amended to include Bereskin & Parr, co-counsel for the Applicants* Filed on 09-JAN-2008 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1009 page(s) 410 - 411 Interlocutory Decision

Copy of a Letter from respondent (Novopharm) dated 10-JAN-2008 advising of service of motion record received on 11-JAN-2008

Covering letter from respondent (Novopharm) dated 11-JAN-2008 concerning Doc. Nos. 31 32 placed on file on 11-JAN-2008

Solicitor's certificate of service on behalf of David W. Aitken confirming service of document no. 31 and Book of Authorities upon all parties by courier on 10-JAN-2008 filed on 11-JAN-2008

Book of Authorities consisting of 1 volume(s) on behalf of Respondent (Novopharm) received on 11-JAN-2008

Motion Record containing the following original document(s): 26 27 28 29 30 Number of copies received: 3 on behalf of Respondent (Novopharm) (3 volumes) filed on 11-JAN-2008

Written Representations contained within a Motion Record on behalf of Respondent (Novopharm) concerning Motion Doc. No. 17 filed on 11-JAN-2008

Affidavit of Christine Ingham sworn on 28-NOV-2007 contained within a Motion Record on behalf of Respondent (Novopharm) in support of Motion Doc. No. 17 with Exhibits a to j filed on 11-JAN-2008

Affidavit of Dr. Michael Chong sworn on 06-NOV-2007 contained within a Motion Record on behalf of Respondent (Novopharm) in support of Motion Doc. No. 17 with Exhibits a filed on 11-JAN-2008

Affidavit of Dr. Peter Rue sworn on 06-NOV-2007 contained within a Motion Record on behalf of Respondent (Novopharm) in support of Motion Doc. No. 17 with Exhibits a to f filed on 11-JAN-2008

Affidavit of Dr. John O. Parker sworn on 06-NOV-2007 contained within a Motion Record on behalf of Respondent (Novopharm) in support of Motion Doc. No. 17 with Exhibits a to j filed on 11-JAN-2008

Memorandum to file from Ottawa Registry dated 24-DEC-2007 Registered mail (certified copy of Order dated November 30, 2007) sent to Solicitors for the Respondent returned/wrong address And resent by registered mail. placed on file.

Solicitor's certificate of service on behalf of Sandra Perri confirming service of doc. 24 upon Respondent by courier on 10-DEC-2007 filed on 11-DEC-2007

Motion Record containing the following original document(s): 21 22 23 Number of copies received: 3 on behalf of Applicant filed on 11-DEC-2007

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion in writing Doc. No. 21 filed on 11-DEC-2007

Consent on behalf of Respondent to 21 filed on 11-DEC-2007

Notice of Motion contained within a Motion Record on behalf of Applicant in writing to be dealt with in the Toronto local office for an Order to ammend the protective order of P. Tabib and other such relief of the Court filed on 11-DEC-2007 Draft Order\\Judgment received.

Order dated 30-NOV-2007 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Order dated 31-OCT-2007 Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is designated as Case Management Judge in this matter. Filed on 30-NOV-2007 entered in J. & O. Book, volume 1006 page(s) 483 - 483 Interlocutory Decision

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 30-NOV-2007 directing that "The hearing scheduled for 2-APR-2008 is re-scheduled to 1-APR-2008, beginning at 9:30 a.m. in Ottawa. The Court thanks the parties for their indulgence in accepting to re-schedule. In view of the shorter time frame between the hearing date and the date scheduled for filing Pfizer's responding record, the Court asks that the said record be filed in Ottawa rather than in Toronto, or, if it be filed in Toronto, that a full electronic copy be forwarded the same day directly to CMT_Ottawa@cas-satj.gc.ca " placed on file on 03-DEC-2007 Confirmed in writing to the party(ies)

Covering letter from Plaintiff dated 09-NOV-2007 concerning 17 18 placed on file on 09-NOV-2007

Solicitor's certificate of service on behalf of Marcus Klee confirming service of Notices of Motion (2) upon all parties by courier on 08-NOV-2007 filed on 09-NOV-2007

Notice of Motion on behalf of Respondent, Novopharm Limited returnable at Special Sitting in Ottawa on 02-APR-2008 to begin at 09:30 for an Order dismissing the application in part pursuant to subsection 6(5)(b) of the ("PM(NOC)Regulations") on the basis that the application is redundant, scandalous, frivolus or vexatious or is otherwise an abuse of process in procees of Canadian Patent N. 2,044,748 (the "'748 Patent")... or such other and further relief as this Honourable Court may deem just. filed on 09-NOV-2007

Notice of Motion on behalf of Respondent, Novopharm Limited returnable at Special Sitting in Ottawa on 23-JAN-2008 to begin at 09:30 for an Order dismissing the application in part pursuant to subsection 6(5)(a) of the PM(NOC)Regulations on the basis that (a) Canadian Patent No. 2,277,017 (the "'017 Patent), (b) Canadian Patent No. 2,285,733 (the "'733 Patent"), (c) Canadian Patent No. 2,290,766 (the "'766 Patent"), (d) Canadian Patent No. 2,324,324 (the "'324 Patent") are not eligible for inclusion on the Patent Register...and such other and further relief as this Honourable Court may deem just. filed on 09-NOV-2007

Order dated 31-OCT-2007 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 8 Result: "IT IS ORDERED THAT:...This application shall proceed as a specially managed proceeding...Pursuant to Section 6(7)(a) of the Regulations, Novopharm shall, no later than November 5, 2007, produce to Pfizer, and the Minister of Health, copies of the pages of Novopharm's Abbreviated New Drug Submission (ANDS) for sildenafil citrate tablets in strengths of 25 mg, 50 mg and 100 mg...the Minister shall, within 30 days of receiving production from Novopharm...verify that the portions of the submission(s) produced by Novopharm correspond fully to the information on file with the Minister Pfizer shall serve its evidence within 120 days of the date that Novopharm conmplies with paragraph 2, and shall file a proof of service thereof no later than five days from the date of service...Respondents shall serve their respective evidence within 120 days of the date that Pfizer serves its evidence, and shall file a proof of service thereof no later than five days from the date of service...Within 10 days of sevice of the Respondents' evidence, the parties shall provide each other with the dates and locations that their affiants are available for cross-examination... Cross-examinations shall be completed within 90 days of the date that the Respondents serve their evidence...A case management conference will be held either immediately before or immediately after the hearing of Novopharm's motion to dismiss scheduled to take place in Ottawa on April 2, 2008, to revise the schedule...Pfizer shall serve and file its Record within 45 days of the date on which the cross-examinations are completed... Respondents shall serve and file their respective Record within 90 days of the date on which the cross-examinations are completed...Novopharm shall, no later than November 9, 2007, serve and file any notice of motion as it intends to bring, pursuant to Section 6(5) of the Regulations...Novopharm's evidence...shall be served no later than November 9, 2007...Pfizer's evidence...served no later than November 30, 2007...Cross-examinations... shall take place...no later than January 4, 2008...Novopharm's full motion record...be served and filed no later than January 11, 2008...Pfizer's full motion record...no later than January 18, 2008...Novopharm's evidence on the '748 patent motion shall be served no later than February 4, 2008...Pfizer's evidence on the '748 patent motion...no later than March 3, 2008...Cross- examinations...no later than March 21, 2008...Novopharm's full motion record on the '748 motion patent...no later than March 26, 2008...Pfizer's full motion record on the '748 patent motion...no later than March 28, 2008." Filed on 31-OCT-2007 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1002 page(s) 48 - 54 Interlocutory Decision

Protective Order dated 31-OCT-2007 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 8 Result: granted Filed on 31-OCT-2007 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1002 page(s) 32 - 40 Interlocutory Decision

Draft Protective Order concerning Motion Doc. No. 8 received on 30-OCT-2007

Ottawa 30-OCT-2007 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Meeting further to Directions dated October 22, 2007 Result of Hearing: Motion concerning S.6(5) of the Patented Medicines (NOC) Regulation is scheduled to take place on January 23, 2008 for a duration of one day at Ottawa; Novopharm Ltd to produce evidence a week from November 9, 2007; Applicants' evidence to be produced by November 23, 2007; Cross-examinations to be completed by January 4, 2008; Novopharm's Record by January 11, 2008; Applicants' Record by January 11, 2008; Motion concerning S.6(7) of the Patented Medicines (NOC) Regulation is scheduled to take place on April 2, 2008 for a duration of one day at Ottawa;November 5, 2007 is the date of production; Novopharm's evidence by February 4, 2008; Applicants to file evidence by March 3, 2008; Cross-examinations to be completed by March 21, 2008; Novopharm's Record by March 26, 2008; Applicants' Record by March 28, 2008; Evidence could be cross-examined twice if the Motion is unsuccessfull: on the Motion and on the Merits; at the Hearing of the Motion on April 2, 2008, the Court will discuss the schedule of the further steps to be taken on the Application or schedule a Case Management Conference; Counsel should submit by electronic mail, a Draft Confidentiality Order held by way of Conference Call in chambers Duration per day: 30-OCT-2007 from 10:03 to 12:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Pauline Chartrand Total Duration: 1h57min Appearances: Andrew Bernstein (416) 865-7678 representing Applicants David W. Aitken and Marcus Klee (613) 787-1077 representing Respondent, Novopharm Limited Draft Decision to be submitted by Respondent, Novopharm Limited Comments: Teleconference held with counsel in their respective offices at Ottawa and Toronto Minutes of Hearing entered in Vol. 760 page(s) 444 - 450 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 29-OCT-2007 directing that "A telephone conference will be held at 10 a.m. on October 30, 2007." Communicated by telephone to the parties placed on file on 29-OCT-2007

Letter from Respondent, Novopharm dated 25-OCT-2007 "... in response to the Direction of the Court...issued on October 22, 2007 ...counsel available to participate in teleconference on October 29, 30, or November 1, 2007..." received on 25-OCT-2007

Written directions received from the Court: Mireille Tabib, Prothonotary dated 22-OCT-2007 directing that "The parties are to provide, as soon as possible, their joint dates of availability to participate in a telephone conference to address whether it is appropriate to reverse the order in which some or all of the evidence is submitted, that is, the Respondent wouldfile some or all of the evidence first and the Applicant file some or all of its evidence in Response. The Court will also seek the parties' representations as to the Court's intention to add in the confidentiality order a provision requiring all material submitted under seal to be accompanied by a certificate of the solicitor of record stating that he or she has reviewed the materials submitted under seal and is satisfied that no non-confidential information is included that cannot be reasonably segregated and filed publicly." placed on file on 22-OCT-2007 Confirmed in writing to the party(ies)

Covering letter from Applicant dated 05-OCT-2007 concerning Doc. No. 14 placed on file on 05-OCT-2007

Consent on behalf of all parties to Draft Orders for special management and confidentiality. (2 Draft Orders - RE: Doc. 8) filed on 05-OCT-2007

Adjournment information received at the Registry on 05-OCT-2007 from Vincent de Grandpré on behalf of Applicant concerning Motion Doc. No. 8 currently scheduled to be heard at General Sitting on 09-OCT-2007 now adjourned sine die

Adjournment letter dated 28-SEP-2007 received on 28-SEP-2007 from Applicant confirming previously recorded adjournment by telephone call received on 28-SEP-2007 placed on file.

Adjournment telephone call received on 28-SEP-2007 from Vincent Grandpre on behalf of Applicant concerning Motion Doc. No. 8 currently scheduled to be heard at General Sitting on 01-OCT-2007 now adjourned to General Sitting in Ottawa on 09-OCT-2007 to begin at 09:30 duration: 45min language: E Letter of confirmation to follow.

Adjournment letter dated 12-SEP-2007 received on 12-SEP-2007 from Applicant concerning Motion Doc. No. 8 currently scheduled to be heard at General Sitting on 17-SEP-2007 now adjourned to General Sitting in Toronto on 01-OCT-2007 to begin at 09:30 duration: 45min language: E placed on file.

Solicitor's certificate of service on behalf of SANDRA PERRI confirming service of APPLICANTS' MOTION RECORD (DOC. 12) AND BRIEF OF AUTHORITIES upon all parties by COURIER on 06-SEP-2007 filed on 06-SEP-2007

BRIEF OF AUTHORITIES (RE: DOC. 8) consisting of 1 volume(s) on behalf of APPLICANTS received on 06-SEP-2007

Motion Record containing the following original document(s): 8 9 10 11 Number of copies received: 3 on behalf of APPLICANTS filed on 06-SEP-2007

Written Representations contained within a Motion Record on behalf of APPLICANTS concerning Motion Doc. No. 8 filed on 06-SEP-2007

Affidavit of DARREN NOSEWORTHY sworn on 05-SEP-2007 contained within a Motion Record on behalf of APPLICANTS in support of Motion Doc. No. 8 filed on 06-SEP-2007

Affidavit of SUE E. WEHNER sworn on 29-AUG-2007 contained within a Motion Record on behalf of APPLICANTS in support of Motion Doc. No. 8 with Exhibits A-C filed on 06-SEP-2007

Notice of Motion contained within a Motion Record on behalf of APPLICANTS returnable at General Sitting in Toronto on 17-SEP-2007 to begin at 09:30 duration: 45min language: E for an Order that this application proceed as a specially managed proceeding, protective order and other relief. (VINCENT GRANDPRE 416.865.8139) filed on 06-SEP-2007

Covering letter from Respondent "Novopharm Limited" dated 29-AUG-2007 concerning Doc. Nos. 6 7 placed on file on 29-AUG-2007

Solicitor's certificate of service on behalf of Bryan A. Norrie confirming service of of the Notice of Appearance (doc. 6) upon Applicants by telecopier on 29-AUG-2007 filed on 29-AUG-2007

Notice of appearance on behalf of the Respondent "Novopharm Limited" filed on 29-AUG-2007

Covering letter from Respondent(Minister of Health) dated 29-AUG-2007 concerning Doc. Nos. 4 5 placed on file on 29-AUG-2007

Affidavit of service of Donna Robinson sworn on 29-AUG-2007 on behalf of Respondent(Minister of Health) confirming service of doc 4 upon all parties by telecopier on 29-AUG-2007 with Exhibits A-B filed on 29-AUG-2007

Notice of appearance on behalf of Respondent(Minister of Health) filed on 29-AUG-2007

Affidavit of service of ROBERT VAN HEZEWYK sworn on 27-AUG-2007 on behalf of Applicant confirming service of DOC 1 upon Respondent NovaPharm by personal service on 27-AUG-2007 filed on 27-AUG-2007

Service copy of Doc. No. 1 with proof of service upon RESPONDENT (DOJ) on 27-AUG-2007 filed on 27-AUG-2007

Notice of application with regard to PM (NOC) Regulations filed on 24-AUG-2007 Certified copy(ies)/copy(ies) transmitted to Director of the Regional Office of the Department of Justice Tariff fee of $50.00 received: yes